Home
HelpTest Code LAB0206185 Lipoprotein Metabolism Profile, Serum
Additional Codes
| Mayo Test ID |
|---|
| LMPP |
Performing Laboratory
Mayo Clinic Laboratories in Rochester
Useful For
Diagnosing dyslipoproteinemia
Quantifying cholesterol and triglycerides in very-low-density lipoprotein, low-density lipoprotein (LDL), high-density lipoproteins (HDL), and chylomicrons
Identifying lipoprotein-X
Classifying hyperlipoproteinemias (lipoprotein phenotyping)
Evaluating patients with abnormal lipid values (cholesterol, triglyceride, HDL, LDL) for specific phenotypes
Method Name
TCS, TRIGD: Enzymatic Colorimetric
APLBS: Automated Turbidimetric Immunoassay
HDLS: Selective Precipitation, Enzymatic Colorimetric
LMPP1: Ultracentrifugation/Electrophoresis/Automated Enzymatic/Colorimetric Analysis
Reporting Name
Lipoprotein Metabolism ProfileSpecimen Type
SerumNecessary Information
Patient's age and sex are required.
Specimen Required
Patient Preparation:
1. Fasting-overnight (12-14 hours)
2. Patient must not consume any alcohol for 24 hours before the specimen is collected.
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 5 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Minimum Volume
2 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Serum | Refrigerated (preferred) | 7 days | |
| Frozen | 60 days |
Reject Due To
| Gross hemolysis | Reject |
| Gross lipemia | OK |
| Gross icterus | Reject |
Reference Values
|
2-9 years |
10-17 years |
≥18 years |
|
|
Total cholesterol |
* Acceptable: <170 mg/dL Borderline high: 170-199 mg/dL High: ≥200 mg/dL |
** Desirable: <200 mg/dL Borderline high: 200-239 mg/dL High: ≥ 240 mg/dL |
|
|
Triglycerides |
* Acceptable: <75 mg/dL Borderline high: 75-99 mg/dL High: ≥100 mg/dL |
* Acceptable: <90 mg/dL Borderline high: 90-129 mg/dL High: ≥130 mg/dL |
** Normal: <150 mg/dL Borderline high: 150-199 mg/dL High: 200-499 mg/dL Very high: ≥500 mg/dL |
|
Low-density lipoprotein (LDL) cholesterol |
* Acceptable: <110 mg/dL Borderline high: 110-129 mg/dL High: ≥130 mg/dL |
*** Desirable: <100 mg/dL Above Desirable: 100-129 mg/dL Borderline high: 130-159 mg/dL High: 160-189 mg/dL Very high: ≥190 mg/dL |
|
|
LDL triglycerides |
≤50 mg/dL |
≤50 mg/dL |
|
|
Apolipoprotein B |
* Acceptable: <90 mg/dL Borderline high: 90-109 mg/dL High: ≥110 mg/dL |
*** Desirable: <90 mg/dL Above Desirable: 90-99mg/dL Borderline high: 100-119 mg/dL High: 120-139 mg/dL Very high: ≥140 mg/dL |
|
|
High-density lipoprotein (HDL) cholesterol |
* Low: <40 mg/dL Borderline low: 40-45 mg/dL Acceptable: >45 mg/dL |
*** Males: ≥40mg/dL Females: ≥50mg/dL |
|
|
Very low-density lipoprotein (VLDL) cholesterol |
<30 mg/dL |
<30 mg/dL |
|
|
VLDL triglycerides |
<90 mg/dL |
<120 mg/dL |
|
|
Beta VLDL cholesterol |
<15 mg/dL |
<15 mg/dL |
|
|
Beta VLDL triglycerides |
<15 mg/dL |
<15 mg/dL |
|
|
Chylomicron cholesterol |
Undetectable |
Undetectable |
|
|
Chylomicron triglycerides |
Undetectable |
Undetectable |
|
|
Lp(a) cholesterol |
<5 mg/dL |
<5 mg/dL |
|
|
LpX |
Undetectable |
Undetectable |
|
Reference values have not been established for patients who are less than 2 years of age.
*Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents
**National Cholesterol Education Program (NCEP)
***National Lipid Association
Interpretation
Patients with increased lipoprotein a (Lp[a]) cholesterol values have been associated with increased risk for the development of atherothrombotic disease. Aggressive low-density lipoprotein reduction is the recommended treatment approach in most patients with increased Lp(a).
Lipoprotein-X (LpX) is an abnormal lipoprotein that appears in the sera of patients with obstructive jaundice and is an indicator of cholestasis. The presence of LpX will be reported if noted during Lp(a) cholesterol analysis.
Day(s) Performed
Monday through Thursday, Sunday
Report Available
2 to 4 daysSpecimen Retention Time
14 daysTest Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80061-Lipid panel (includes: HDL [CPT Code 83718], total cholesterol [CPT Code 82465], and triglycerides [CPT Code 84478] if all performed)
82172-Apolipoprotein B
83700-Lp(a) cholesterol electrophoresis
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| LMPP | Lipoprotein Metabolism Profile | In Process |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| TCS | Cholesterol, Total, CDC, S | 2093-3 |
| HDLS | HDL Cholesterol, CDC, S | 2085-9 |
| TRIGC | Triglycerides, CDC, S | 2571-8 |
| APLBS | Apolipoprotein B, S | 1884-6 |
| 2839 | LDL Cholesterol | 2089-1 |
| 2840 | LDL Triglycerides | 3046-0 |
| 2844 | VLDL cholesterol | 2091-7 |
| 2847 | VLDL triglycerides | 3047-8 |
| 2842 | Beta VLDL Cholesterol | 66499-5 |
| 2843 | Beta VLDL triglycerides | 3045-2 |
| 2855 | Chylomicron cholesterol | 34467-1 |
| 2856 | Chylomicron triglycerides | 35363-1 |
| 2849 | Lp(a) Cholesterol | 35388-8 |
| 23924 | LpX | 42178-4 |
| 23937 | Interpretation | 59462-2 |
Profile Information
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| TCS | Cholesterol, Total, CDC, S | No | Yes |
| TRIGC | Triglycerides, CDC, S | No | Yes |
| APLBS | Apolipoprotein B, S | Yes, (order APOLB) | Yes |
| HDLS | HDL Cholesterol, CDC, S | No | Yes |
| LMPP1 | Lipoprotein Metabolism Profile 1 | No | Yes |
Forms
If not ordering electronically, complete, print, and send a Cardiovascular Test Request Form (T724) with the specimen.